Found 47 matching trials
Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma
PHASE3Retinoblastoma is a childhood cancer which affects the retina of the eye. T...
Location
St. Jude Children's Research Hospital
N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
PHASE2The purpose of this study is to find out whether N10 chemotherapy is a safe...
Location
Memorial Sloan Kettering Cancer Center
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma
PHASE2Background:
Advanced urothelial cancer has no cure. But only a few chemoth...
Location
National Institutes of Health Clinical Center
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
PHASE2This phase II trial studies how well combination chemotherapy works in trea...
Location
Children's Hospital of Alabama
Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma
PHASE3RATIONALE: Drugs used in chemotherapy, such as vincristine, doxorubicin, cy...
Location
Multiple Locations
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
PHASE3This randomized phase III trial compares two different high-dose chemothera...
Location
Children's Hospital of Alabama
Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma
PHASE1Funding Source - FDA OOPD FDR004128
The goal of this study is to see if it...
Location
Memorial Sloan Kettering Cancer Center
New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma
PHASE2The prognosis for patients with metastatic Ewing's sarcoma family of tumors...
Location
National Cancer Institute (NCI)
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
PHASE1This pilot clinical trial studies busulfan, melphalan, and stem cell transp...
Location
Children's Hospital of Alabama
Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas
PHASE3Data from 40 patients are planned to be included in the study to randomize ...